Learn More
Background 2´-Deoxy-5-fluorouridylyl-(5´-5´)-3´-C-ethynylcytidine [5-FdU(5´-5´)ECyd] and 3´-C-ethynylcytidinylyl-(5´->1-O)-2-O-octadecyl-sn-glycerylyl-(3-Ο−>5´)-2´-deoxy-5-fluorouridine(More)
Bisphosphonates (BPs) are bone specific palliative therapeutics that reduce tumorand cancer treatment-induced skeletal complication [1–3]. Further, they are an effective treatment for preventing(More)
  • 1